1 |
(minus)-l-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate |
- |
- |
- |
- |
006 1件: 6 💬 |
2 |
10 mg natura-alpha capsule |
- |
- |
- |
- |
097 1件: 97 💬 |
3 |
100 µg brimonidine tartrate implant |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
4 |
1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- |
- |
- |
- |
- |
006 1件: 6 💬 |
5 |
1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea |
- |
- |
- |
- |
006 1件: 6 💬 |
6 |
1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- |
- |
- |
- |
- |
006 1件: 6 💬 |
7 |
1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea |
- |
- |
- |
- |
006 1件: 6 💬 |
8 |
2 x 10 mg natura-alpha capsules |
- |
- |
- |
- |
097 1件: 97 💬 |
9 |
2% chlorhexidine solution wipes |
Chlorhexidine |
4件: D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 1件: 299 💬 |
10 |
200 µg brimonidine tartrate implant |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
11 |
3-(3,4-dihydroxyphenyl)-l-alanine |
Alanine |
1件: D00012 D00012 💬 |
- |
- |
006 1件: 6 💬 |
12 |
3h-cholesterol bound to albumin |
Cholesterol |
1件: D00040 D00040 💬 |
- |
- |
259 2件: 259, 261 💬 |
13 |
4% chlorhexidine gluconate liquid skin cleanser |
Chlorhexidine |
4件: D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 1件: 299 💬 |
14 |
400 µg brimonidine tartrate implant |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
15 |
5% lidocaine/5 mg/ml 0.02% estradiol compound cream |
Estradiol |
11件: D00105 D00105, D00358 D00358, D01413 D01413, D01617 D01617, D01953 D01953, D02086 D02086, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065, D08127 D08127 💬 |
ESR1 7件: ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 12件: Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway |
226 1件: 226 💬 |
16 |
6 alpha-ethylchenodeoxycholic acid (6-edca), oca, int-747 |
- |
- |
- |
- |
093 1件: 93 💬 |
17 |
89 zirconium recombinant human alpha-n-acetylglucosaminidase (rhnaglu) (radiolabeled) |
- |
- |
- |
- |
019 1件: 19 💬 |
18 |
90 mg hydrocortisone acetate suppository with sephure suppository applicator |
Acetate |
2件: D00088 D00088, D00165 D00165 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
19 |
98% dehydrated alcohol |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
298 1件: 298 💬 |
20 |
[allo-apz2-eb] |
- |
- |
- |
- |
036 1件: 36 💬 |
21 |
Abi-009, nab-rapamycin, albumin-bound rapamycin |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
086 1件: 86 💬 |
22 |
Adempas - 0,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
086 1件: 86 💬 |
23 |
Adempas - 1 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
24 |
Adempas - 1,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
25 |
Adempas - 2 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
26 |
Adempas - 2,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 2件: 51, 86 💬 |
27 |
Adeno-associated viral vector serotype 9 containing the human n-acetyl-alpha-glucosaminidase gene |
- |
- |
- |
- |
019 1件: 19 💬 |
28 |
Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase a cdna |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
29 |
Aerosolized human alpha-1 antitrypsin |
- |
- |
- |
- |
231 1件: 231 💬 |
30 |
Aerosolized, human, plasma-derived alpha-1 antitrypsin |
- |
- |
- |
- |
299 1件: 299 💬 |
31 |
Agalsidase alfa |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
32 |
Agalsidase alpha |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
33 |
Al |
- |
- |
- |
- |
005 9件: 5 , 6 , 7 , 28, 51, 67, 86, 114, 127 💬 |
34 |
Al-108 |
- |
- |
- |
- |
005 1件: 5 💬 |
35 |
Al001 |
- |
- |
- |
- |
127 1件: 127 💬 |
36 |
Ala |
- |
- |
- |
- |
286 1件: 286 💬 |
37 |
Alanine |
Alanine |
1件: D00012 D00012 💬 |
- |
- |
006 4件: 6 , 13, 298, 299 💬 |
38 |
Albendazole |
Albendazole |
1件: D00134 D00134 💬 |
- |
- |
096 1件: 96 💬 |
39 |
Albendazole (eskazole) |
Albendazole |
1件: D00134 D00134 💬 |
- |
- |
096 1件: 96 💬 |
40 |
Albumen |
Egg white |
- |
- |
- |
096 1件: 96 💬 |
41 |
Albumin |
- |
- |
- |
- |
002 3件: 2 , 20, 51 💬 |
42 |
Albumin (human) 20%, united states pharmacopeia (usp) |
- |
- |
- |
- |
231 1件: 231 💬 |
43 |
Albumin (human) 25%, united states pharmacopeia (usp) |
- |
- |
- |
- |
013 2件: 13, 14 💬 |
44 |
Albumin solution |
- |
- |
- |
- |
020 1件: 20 💬 |
45 |
Albumine humaine |
- |
- |
- |
- |
096 1件: 96 💬 |
46 |
Albunorm® 5%, |
- |
- |
- |
- |
020 1件: 20 💬 |
47 |
Albutein 5% |
- |
- |
- |
- |
002 1件: 2 💬 |
48 |
Albuterol |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
012 8件: 12, 13, 86, 89, 113, 231, 256, 299 💬 |
49 |
Albuterol first |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
50 |
Albuterol inhaler |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
089 1件: 89 💬 |
51 |
Albuterol inhaler. |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
231 2件: 231, 299 💬 |
52 |
Albuterol nebulizer |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
089 1件: 89 💬 |
53 |
Albuterol. |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
54 |
Albutropin |
- |
- |
- |
- |
078 1件: 78 💬 |
55 |
Albúmina humana |
- |
- |
- |
- |
002 1件: 2 💬 |
56 |
Alcohol |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 4件: 13, 58, 279, 298 💬 |
57 |
Ald518 |
- |
- |
- |
- |
046 1件: 46 💬 |
58 |
Ald518 monoclonal antibody (anti il-6 mab) |
- |
- |
- |
- |
046 1件: 46 💬 |
59 |
Aldesleuchina |
- |
- |
- |
- |
049 1件: 49 💬 |
60 |
Aldesleukin |
Aldesleukin |
1件: D00748 D00748 💬 |
IL2RA 3件: IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction 14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 4件: 49, 65, 96, 97 💬 |
61 |
Aldosterone |
Aldosterone |
1件: D10528 D10528 💬 |
NR3C2 1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
222 1件: 222 💬 |
62 |
Aldurazyme |
- |
- |
- |
- |
019 1件: 19 💬 |
63 |
Aldurazyme (laronidase) |
Laronidase |
1件: D04670 D04670 💬 |
IDUA 1件: IDUA 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 2件: 19, 256 💬 |
64 |
Aldurazyme (recombinant human alpha-l-iduronidase) |
- |
- |
- |
- |
019 1件: 19 💬 |
65 |
Aldurazyme*infus 1fl 5ml 500u |
- |
- |
- |
- |
019 1件: 19 💬 |
66 |
Alefacept |
Alefacept |
1件: D02800 D02800 💬 |
CD58 1件: CD58 💬 |
Cell adhesion molecules 2件: Cell adhesion molecules, Epstein-Barr virus infection |
037 6件: 37, 60, 65, 164, 284, 285 💬 |
67 |
Alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 16件: 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
68 |
Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994 |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
046 1件: 46 💬 |
69 |
Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
046 1件: 46 💬 |
70 |
Alemtuzumab (campath ) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
060 1件: 60 💬 |
71 |
Alemtuzumab (campath) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
015 1件: 15 💬 |
72 |
Alemtuzumab (gz402673) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
73 |
Alemtuzumab 0.2 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
065 2件: 65, 164 💬 |
74 |
Alemtuzumab 0.3 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
065 2件: 65, 164 💬 |
75 |
Alemtuzumab 12 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
76 |
Alemtuzumab 24 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
77 |
Alemtuzumab and rituximab |
Alemtuzumab |
2件: D02802 D02802, D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
060 1件: 60 💬 |
78 |
Alemtuzumab gz402673 |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
79 |
Alemtuzumab immunotherapy |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
80 |
Alemtuzumab injection |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
81 |
Alemtuzumab injection [lemtrada] |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
82 |
Alemtuzumab, rituximab |
Alemtuzumab |
2件: D02802 D02802, D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
063 1件: 63 💬 |
83 |
Alendronat teva |
- |
- |
- |
- |
046 1件: 46 💬 |
84 |
Alendronate |
Alendronic acid |
2件: D00939 D00939, D07119 D07119 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
019 7件: 19, 41, 46, 50, 271, 274, 299 💬 |
85 |
Alendronate sodium |
Alendronic acid |
2件: D00939 D00939, D07119 D07119 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
019 2件: 19, 299 💬 |
86 |
Alendronate versus alfacalcidol (1-alpha oh vitamin d) |
Alendronic acid |
3件: D00939 D00939, D01518 D01518, D07119 D07119 💬 |
FDPS 2件: FDPS, VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 8件: Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis |
041 3件: 41, 46, 50 💬 |
87 |
Alendronic acid |
Alendronic acid |
2件: D00939 D00939, D07119 D07119 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
046 2件: 46, 274 💬 |
88 |
Alentuzumab (campath) |
- |
- |
- |
- |
065 1件: 65 💬 |
89 |
Alequel |
- |
- |
- |
- |
096 1件: 96 💬 |
90 |
Alfa-manosidadas humana recombinante |
- |
- |
- |
- |
019 1件: 19 💬 |
91 |
Alfacalcidol |
Alfacalcidol |
1件: D01518 D01518 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
041 6件: 41, 46, 49, 50, 96, 235 💬 |
92 |
Alfacalcidol 2 micrograms/ml |
Alfacalcidol |
1件: D01518 D01518 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
050 1件: 50 💬 |
93 |
Alfuzosin |
Alfuzosin |
2件: D01692 D01692, D07124 D07124 💬 |
ADRA1A 1件: ADRA1A 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
94 |
Alga dunaliella bardawil |
- |
- |
- |
- |
090 1件: 90 💬 |
95 |
Alga dunaliella bardawil powder |
- |
- |
- |
- |
090 1件: 90 💬 |
96 |
Alga dunaliella bardawill |
- |
- |
- |
- |
090 1件: 90 💬 |
97 |
Alginate |
Alginic acid |
1件: D02324 D02324 💬 |
- |
- |
053 2件: 53, 299 💬 |
98 |
Alginate oligosaccharide |
Alginic acid |
1件: D02324 D02324 💬 |
- |
- |
299 1件: 299 💬 |
99 |
Alginic acid |
Alginic acid |
1件: D02324 D02324 💬 |
- |
- |
051 1件: 51 💬 |
100 |
Alglucosidase alfa |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
101 |
Alglucosidase alfa (genetical recombination) |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
102 |
Alglucosidase alfa (gz419829) |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
103 |
Alglucosidase alfa (myozyme) |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
104 |
Alglucosidase alfa (recombinant human acid alpha-glucosidase [rhgaa]) |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
105 |
Alglucosidase alfa gz419829 |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
106 |
Alglucosidase alpha |
- |
- |
- |
- |
256 1件: 256 💬 |
107 |
Alicaforsen |
Alicaforsen |
- |
- |
- |
096 2件: 96, 97 💬 |
108 |
Alicalm (polymeric liquid formula) |
- |
- |
- |
- |
096 1件: 96 💬 |
109 |
Alirocumab |
Alirocumab |
1件: D10335 D10335 💬 |
PCSK9 1件: PCSK9 💬 |
Cholesterol metabolism 1件: Cholesterol metabolism |
079 1件: 79 💬 |
110 |
Alirocumab sar236553 (regn727) |
Alirocumab |
1件: D10335 D10335 💬 |
PCSK9 1件: PCSK9 💬 |
Cholesterol metabolism 1件: Cholesterol metabolism |
079 1件: 79 💬 |
111 |
Aliskiren |
Aliskiren |
1件: D03208 D03208 💬 |
REN 1件: REN 💬 |
Diabetic cardiomyopathy 3件: Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system |
066 4件: 66, 167, 222, 223 💬 |
112 |
Alitretinoin |
Alitretinoin |
1件: D02815 D02815 💬 |
RARA 5件: RARA, RARB, RXRA, RXRB, RXRG 💬 |
Acute myeloid leukemia 17件: Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer |
049 1件: 49 💬 |
113 |
Alk-001 |
- |
- |
- |
- |
301 1件: 301 💬 |
114 |
Alk-001 (no generic name) |
- |
- |
- |
- |
301 1件: 301 💬 |
115 |
Alkaline phosphatase |
Alkaline Phosphatase |
- |
- |
- |
046 4件: 46, 93, 97, 172 💬 |
116 |
Alkalinized lidocaine-heparin |
Heparin |
4件: D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 1件: 226 💬 |
117 |
Alkeran |
- |
- |
- |
- |
028 2件: 28, 60 💬 |
118 |
Alks 8700 |
- |
- |
- |
- |
013 1件: 13 💬 |
119 |
Alks 8700 delayed release (dr) |
- |
- |
- |
- |
013 1件: 13 💬 |
120 |
Alks 8700 delayed release (dr) capsule |
- |
- |
- |
- |
013 1件: 13 💬 |
121 |
All subjects will receive maraviroc 300mg orally twice a day for 6 weeks |
Maraviroc |
1件: D06670 D06670 💬 |
CCR5 1件: CCR5 💬 |
Chemokine signaling pathway 9件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor |
084 1件: 84 💬 |
122 |
All-trans retinoic acid |
Tretinoin |
1件: D00094 D00094 💬 |
PML 3件: PML, RARA, RARB 💬 |
Acute myeloid leukemia 12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
094 1件: 94 💬 |
123 |
All-trans retinoid acid(atra) |
Tretinoin |
1件: D00094 D00094 💬 |
PML 3件: PML, RARA, RARB 💬 |
Acute myeloid leukemia 12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
063 1件: 63 💬 |
124 |
Allantoin |
Allantoin |
1件: D00121 D00121 💬 |
- |
- |
036 1件: 36 💬 |
125 |
Allergen |
- |
- |
- |
- |
098 1件: 98 💬 |
126 |
Allergy immunotherapy (allergy shots) |
- |
- |
- |
- |
098 1件: 98 💬 |
127 |
Allo-apz2-eb |
- |
- |
- |
- |
036 1件: 36 💬 |
128 |
Allo-asc |
- |
- |
- |
- |
096 1件: 96 💬 |
129 |
Allo-asc-cd |
- |
- |
- |
- |
096 1件: 96 💬 |
130 |
Allo-asc-dfu |
- |
- |
- |
- |
036 1件: 36 💬 |
131 |
Allo-hmscs |
- |
- |
- |
- |
211 2件: 211, 299 💬 |
132 |
Allogen-li |
- |
- |
- |
- |
070 1件: 70 💬 |
133 |
Allogeneic adipose tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
097 1件: 97 💬 |
134 |
Allogeneic adipose tissue-derived mesenchymal stem cells expanded |
- |
- |
- |
- |
053 1件: 53 💬 |
135 |
Allogeneic adipose tissue-derived stromal/stem cells |
- |
- |
- |
- |
053 1件: 53 💬 |
136 |
Allogeneic adult human mesenchymal stem cells (hmscs) |
Remestemcel-L |
1件: D09719 D09719 💬 |
- |
- |
085 1件: 85 💬 |
137 |
Allogeneic bone marrow derived human mesenchymal stem cells (hmscs) |
- |
- |
- |
- |
096 1件: 96 💬 |
138 |
Allogeneic bone marrow transplant |
- |
- |
- |
- |
049 1件: 49 💬 |
139 |
Allogeneic bone marrow-derived mscs (1 x 10 6 msc/kg) |
- |
- |
- |
- |
006 1件: 6 💬 |
140 |
Allogeneic bone marrow-derived mscs (10 x 10 6 msc/kg) |
- |
- |
- |
- |
006 1件: 6 💬 |
141 |
Allogeneic bone marrow-derived mscs (3 x 10 6 msc/kg) |
- |
- |
- |
- |
006 1件: 6 💬 |
142 |
Allogeneic bone marrow-derived mscs (6 x 10 6 msc/kg) |
- |
- |
- |
- |
006 1件: 6 💬 |
143 |
Allogeneic cardiosphere-derived cells (cap-1002) |
CAP-1002 |
- |
- |
- |
113 1件: 113 💬 |
144 |
Allogeneic donor derived b-lymphocytes |
- |
- |
- |
- |
060 1件: 60 💬 |
145 |
Allogeneic fecal microbiota |
- |
- |
- |
- |
013 1件: 13 💬 |
146 |
Allogeneic human cardiosphere-derived stem cells |
- |
- |
- |
- |
086 1件: 86 💬 |
147 |
Allogeneic human umbilical cord tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
013 1件: 13 💬 |
148 |
Allogeneic mesenchymal precursor cells |
- |
- |
- |
- |
046 1件: 46 💬 |
149 |
Allogeneic mesenchymal stem cells |
- |
- |
- |
- |
047 1件: 47 💬 |
150 |
Allogeneic mesenchymal stem cells (allomsc) |
- |
- |
- |
- |
051 2件: 51, 53 💬 |
151 |
Allogeneic mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
036 1件: 36 💬 |
152 |
Allogeneic mesenchymal stromal cells derived from the umbilical cord |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
049 1件: 49 💬 |
153 |
Allogeneic msc (allomsc) |
- |
- |
- |
- |
049 1件: 49 💬 |
154 |
Allogeneic neural retina-derived human neural retinal progenitor cells ex vivo expanded |
- |
- |
- |
- |
090 1件: 90 💬 |
155 |
Allogeneic peripheral blood stem cell |
- |
- |
- |
- |
065 1件: 65 💬 |
156 |
Allogeneic skin-derived abcb5-positive mesenchymal stem cells |
- |
- |
- |
- |
036 1件: 36 💬 |
157 |
Allogeneic stem cell therapy |
- |
- |
- |
- |
096 1件: 96 💬 |
158 |
Allogeneic stem cell transplant |
- |
- |
- |
- |
053 2件: 53, 56 💬 |
159 |
Allogeneic stem cell transplantation |
- |
- |
- |
- |
049 2件: 49, 84 💬 |
160 |
Allogenic eascs 5 milion cells/ml suspension for injection. cx601 |
- |
- |
- |
- |
096 1件: 96 💬 |
161 |
Allogenic eascs 5 million cells/ml suspension for injection cx601 |
- |
- |
- |
- |
096 1件: 96 💬 |
162 |
Allogenic eascs 5 million cells/ml suspension for injection. cx601 |
- |
- |
- |
- |
096 1件: 96 💬 |
163 |
Allogenic eascs 5 million/ml suspension for injection. |
- |
- |
- |
- |
096 1件: 96 💬 |
164 |
Allogenic human heterologous liver cells |
- |
- |
- |
- |
251 1件: 251 💬 |
165 |
Allogenic mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
036 1件: 36 💬 |
166 |
Allopregnanolone |
Brexanolone |
1件: D11149 D11149 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
205 1件: 205 💬 |
167 |
Allopurinol |
Allopurinol |
1件: D00224 D00224 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
006 6件: 6 , 46, 57, 66, 96, 97 💬 |
168 |
Allopurinol sandoz 100 mg, tabletten |
Allopurinol |
1件: D00224 D00224 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
096 1件: 96 💬 |
169 |
Allopurinol sodium |
Allopurinol |
1件: D00224 D00224 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
096 1件: 96 💬 |
170 |
Aln-51547 |
- |
- |
- |
- |
028 1件: 28 💬 |
171 |
Aln-60212 |
- |
- |
- |
- |
079 1件: 79 💬 |
172 |
Aln-60519 |
- |
- |
- |
- |
254 1件: 254 💬 |
173 |
Aln-61444 |
- |
- |
- |
- |
231 1件: 231 💬 |
174 |
Aln-62643 |
- |
- |
- |
- |
062 1件: 62 💬 |
175 |
Aln-65585 |
- |
- |
- |
- |
234 1件: 234 💬 |
176 |
Aln-77412 |
- |
- |
- |
- |
231 1件: 231 💬 |
177 |
Aln-aat |
- |
- |
- |
- |
231 1件: 231 💬 |
178 |
Aln-aat02 |
- |
- |
- |
- |
231 1件: 231 💬 |
179 |
Aln-as1 |
- |
- |
- |
- |
254 1件: 254 💬 |
180 |
Aln-cc5 |
- |
- |
- |
- |
062 3件: 62, 66, 109 💬 |
181 |
Aln-go1 |
- |
- |
- |
- |
234 1件: 234 💬 |
182 |
Aln-pcssc |
Inclisiran |
1件: D11931 D11931 💬 |
PCSK9 1件: PCSK9 💬 |
Cholesterol metabolism 1件: Cholesterol metabolism |
079 1件: 79 💬 |
183 |
Aln-ttrsc |
- |
- |
- |
- |
028 1件: 28 💬 |
184 |
Aloasc |
- |
- |
- |
- |
097 1件: 97 💬 |
185 |
Aloe |
Aloe Vera Leaf |
- |
- |
- |
097 1件: 97 💬 |
186 |
Aloe barbadensis miller |
Aloe Vera Leaf |
- |
- |
- |
097 1件: 97 💬 |
187 |
Aloe vera |
Aloe Vera Leaf |
- |
- |
- |
053 1件: 53 💬 |
188 |
Alofisel |
- |
- |
- |
- |
096 1件: 96 💬 |
189 |
Alpha 1-antitrypsin |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 2件: 231, 298 💬 |
190 |
Alpha 1-proteinase inhibitor |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 1件: 231 💬 |
191 |
Alpha 1-proteinase inhibitor (human) |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 1件: 231 💬 |
192 |
Alpha beta depletion |
- |
- |
- |
- |
060 2件: 60, 284 💬 |
193 |
Alpha interferon |
- |
- |
- |
- |
056 1件: 56 💬 |
194 |
Alpha lipoic acid |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
013 1件: 13 💬 |
195 |
Alpha-1 antitrypsin (aat) |
- |
- |
- |
- |
231 1件: 231 💬 |
196 |
Alpha-1 antitrypsin (human) |
- |
- |
- |
- |
231 1件: 231 💬 |
197 |
Alpha-1 hc 100 mg |
- |
- |
- |
- |
299 1件: 299 💬 |
198 |
Alpha-1 hc 200 mg |
- |
- |
- |
- |
299 1件: 299 💬 |
199 |
Alpha-1 mp |
- |
- |
- |
- |
231 1件: 231 💬 |
200 |
Alpha-1 proteinase inhibitor (human) |
- |
- |
- |
- |
231 1件: 231 💬 |
201 |
Alpha-1-antitrypsin |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 1件: 231 💬 |
202 |
Alpha-2c ar antagonist |
- |
- |
- |
- |
051 1件: 51 💬 |
203 |
Alpha-galactosidase a |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
204 |
Alpha-glucosidase |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
205 |
Alpha-lipoic acid |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
002 2件: 2 , 13 💬 |
206 |
Alpha-lipoic acid and l-acetyl carnitine |
Levocarnitine |
5件: D00048 D00048, D00086 D00086, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 1件: 5 💬 |
207 |
Alpha-tocopherol |
Tocopherol |
2件: D02331 D02331, D02332 D02332 💬 |
- |
- |
049 2件: 49, 206 💬 |
208 |
Alpha-tocotrienol quinone |
Tocotrienol |
- |
- |
- |
156 1件: 156 💬 |
209 |
Alpha1-antitrypsin |
- |
- |
- |
- |
013 1件: 13 💬 |
210 |
Alpha1-proteinase inhibitor |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 2件: 231, 299 💬 |
211 |
Alpha1-proteinase inhibitor (human) |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 2件: 231, 299 💬 |
212 |
Alphanate |
- |
- |
- |
- |
288 1件: 288 💬 |
213 |
Alphanate 1000 i.u. |
- |
- |
- |
- |
288 1件: 288 💬 |
214 |
Alphanate 1500 i.u. |
- |
- |
- |
- |
288 1件: 288 💬 |
215 |
Alphanate sd/ht |
- |
- |
- |
- |
288 1件: 288 💬 |
216 |
Alphanate*inf 1f 1000ui+f 10ml |
- |
- |
- |
- |
288 1件: 288 💬 |
217 |
Alphanate*inf 1f 1500ui+f 10ml |
- |
- |
- |
- |
288 1件: 288 💬 |
218 |
Alphanate*inf 1f 250ui+f 5ml |
- |
- |
- |
- |
288 1件: 288 💬 |
219 |
Alphanate*inf 1f 500ui+f 5ml |
- |
- |
- |
- |
288 1件: 288 💬 |
220 |
Alprazolam |
Alprazolam |
1件: D00225 D00225 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
008 1件: 8 💬 |
221 |
Alprostadil |
Alprostadil |
2件: D00180 D00180, D02705 D02705 💬 |
PTGER1 1件: PTGER1 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer |
051 2件: 51, 70 💬 |
222 |
Alrn-5281 0.015 mg/kg |
- |
- |
- |
- |
078 1件: 78 💬 |
223 |
Alrn-5281 0.05 mg/kg |
- |
- |
- |
- |
078 1件: 78 💬 |
224 |
Alrn-5281 0.15 mg/kg |
- |
- |
- |
- |
078 1件: 78 💬 |
225 |
Alth12-1:4 |
- |
- |
- |
- |
097 1件: 97 💬 |
226 |
Alth12-2:4 |
- |
- |
- |
- |
097 1件: 97 💬 |
227 |
Altri farmaci del sistema nervoso |
- |
- |
- |
- |
013 1件: 13 💬 |
228 |
Altropane |
Altropane |
- |
- |
- |
006 1件: 6 💬 |
229 |
Altropane® |
Altropane |
- |
- |
- |
006 1件: 6 💬 |
230 |
Altu-135 |
ALTU-135 |
- |
- |
- |
299 1件: 299 💬 |
231 |
Altu-238 |
- |
- |
- |
- |
078 1件: 78 💬 |
232 |
Altus-135 |
- |
- |
- |
- |
299 1件: 299 💬 |
233 |
Aluminium |
Aluminium |
- |
- |
- |
046 1件: 46 💬 |
234 |
Aluminium hydroxide |
Aluminium |
1件: D02416 D02416 💬 |
- |
- |
046 1件: 46 💬 |
235 |
Aluminium phosphate |
Aluminium |
- |
- |
- |
046 1件: 46 💬 |
236 |
Alvarez 2 |
- |
- |
- |
- |
037 1件: 37 💬 |
237 |
Alvelestat |
Alvelestat |
- |
- |
- |
231 1件: 231 💬 |
238 |
Alvelestat (mph966) |
Alvelestat |
- |
- |
- |
231 1件: 231 💬 |
239 |
Alvelestat oral tablet - dose 1 |
Alvelestat |
- |
- |
- |
231 1件: 231 💬 |
240 |
Alvelestat oral tablet - dose 2 |
Alvelestat |
- |
- |
- |
231 1件: 231 💬 |
241 |
Alvelestat tosylate |
Alvelestat |
- |
- |
- |
231 1件: 231 💬 |
242 |
Alwextin cream |
- |
- |
- |
- |
036 1件: 36 💬 |
243 |
Alx-0061 |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
244 |
Alx-0061 150 mg/ml |
- |
- |
- |
- |
049 1件: 49 💬 |
245 |
Alx-0061 nanobody |
- |
- |
- |
- |
046 1件: 46 💬 |
246 |
Alx-0081 |
- |
- |
- |
- |
064 1件: 64 💬 |
247 |
Alx-009 |
- |
- |
- |
- |
299 1件: 299 💬 |
248 |
Alx-0600 |
- |
- |
- |
- |
096 1件: 96 💬 |
249 |
Alxn1102 |
- |
- |
- |
- |
062 1件: 62 💬 |
250 |
Alxn1103 |
- |
- |
- |
- |
062 1件: 62 💬 |
251 |
Alxn1210 |
- |
- |
- |
- |
002 5件: 2 , 11, 13, 62, 109 💬 |
252 |
Alxn1830 |
- |
- |
- |
- |
035 2件: 35, 61 💬 |
253 |
Alxn1840 |
- |
- |
- |
- |
171 1件: 171 💬 |
254 |
Alxn2040 (ach-0144471) |
- |
- |
- |
- |
062 2件: 62, 222 💬 |
255 |
Alxn2050 |
- |
- |
- |
- |
062 1件: 62 💬 |
256 |
Alzt-op1a (cromolyn) |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
002 1件: 2 💬 |
257 |
Ambrisentan plus spironolactone |
Ambrisentan |
2件: D00443 D00443, D07077 D07077 💬 |
EDNRA 2件: EDNRA, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 8件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
258 |
Amitriptyline, fluoxetine and tramadol alone (control group) |
Amitriptyline |
6件: D00326 D00326, D00809 D00809, D00823 D00823, D01355 D01355, D07448 D07448, D08623 D08623 💬 |
OPRM1 3件: OPRM1, SLC6A2, SLC6A4 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
078 1件: 78 💬 |
259 |
Amniotic fluid allograft |
- |
- |
- |
- |
070 1件: 70 💬 |
260 |
Andrographis paniculata (ethanol extract) |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
097 1件: 97 💬 |
261 |
Anti lymphotoxin alpha |
- |
- |
- |
- |
046 1件: 46 💬 |
262 |
Anti tnf alfa. |
- |
- |
- |
- |
096 1件: 96 💬 |
263 |
Anti tnf alpha agent |
- |
- |
- |
- |
271 1件: 271 💬 |
264 |
Anti tnf alpha therapy |
- |
- |
- |
- |
271 1件: 271 💬 |
265 |
Anti-gm-csf receptor alpha |
- |
- |
- |
- |
046 1件: 46 💬 |
266 |
Anti-integrin alphav mab |
- |
- |
- |
- |
051 1件: 51 💬 |
267 |
Anti-tnf-alpha |
- |
- |
- |
- |
046 1件: 46 💬 |
268 |
Antituberculous therapy along with steroids |
- |
- |
- |
- |
084 1件: 84 💬 |
269 |
Apadamtase alfa |
Apadamtase alfa |
- |
- |
- |
064 1件: 64 💬 |
270 |
Apademtase alfa |
- |
- |
- |
- |
064 1件: 64 💬 |
271 |
Arthroscopy & saline irrigation alone |
- |
- |
- |
- |
046 1件: 46 💬 |
272 |
Ascorbic acid (vitamin c) and alpha-tocopherol (vitamin e) |
Ascorbic acid |
3件: D00018 D00018, D02331 D02331, D02332 D02332 💬 |
- |
- |
206 1件: 206 💬 |
273 |
Asfotas alfa |
- |
- |
- |
- |
172 1件: 172 💬 |
274 |
Asfotase alfa |
Asfotase alfa |
1件: D10595 D10595 💬 |
ALPL 1件: ALPL 💬 |
Biosynthesis of cofactors 4件: Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism |
172 1件: 172 💬 |
275 |
Asfotase alfa (alxn1215) |
Asfotase alfa |
1件: D10595 D10595 💬 |
ALPL 1件: ALPL 💬 |
Biosynthesis of cofactors 4件: Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism |
172 1件: 172 💬 |
276 |
Aubagio - 14 mg - compressa rivestita con film - uso orale - blister (alu/alu) - 28 compresse |
- |
- |
- |
- |
013 1件: 13 💬 |
277 |
Autologous cd34+ cells transduced with the lentiviral vector containing the human wiskott aldrich sy |
- |
- |
- |
- |
065 1件: 65 💬 |
278 |
Autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with lentiviral vector that encodes for the human wiskott aldrich syndrome (was) cdna sequence |
- |
- |
- |
- |
065 1件: 65 💬 |
279 |
Avalglucosidase alfa |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
280 |
Avalglucosidase alfa (neogaa) |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
281 |
Avalglucosidase alfa gz402666 |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
282 |
Avalglucosidase alfa(gz402666) |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
283 |
Avalox - 400 mg compresse rivestite con film 5 compresse in blister pp/al |
- |
- |
- |
- |
006 1件: 6 💬 |
284 |
Azathioprine and allopurinol |
Allopurinol |
3件: D00224 D00224, D00238 D00238, D03033 D03033 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
097 1件: 97 💬 |
285 |
Azd3241 alternative titration scheme with formulation 1 or 2 |
- |
- |
- |
- |
006 1件: 6 💬 |
286 |
Baminercept |
Baminercept |
1件: D08866 D08866 💬 |
LTB 1件: LTB 💬 |
Cytokine-cytokine receptor interaction 3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 53, 97 💬 |
287 |
Baminercept alfa |
Baminercept |
1件: D08866 D08866 💬 |
LTB 1件: LTB 💬 |
Cytokine-cytokine receptor interaction 3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 1件: 46 💬 |
288 |
Baminercept alfa (bg9924) |
Baminercept |
1件: D08866 D08866 💬 |
LTB 1件: LTB 💬 |
Cytokine-cytokine receptor interaction 3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 1件: 46 💬 |
289 |
Behavioral: smoking and alcohol assumption |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
298 1件: 298 💬 |
290 |
Benzbromaron al |
- |
- |
- |
- |
086 1件: 86 💬 |
291 |
Benzoyl-l-tyrosyl-[1-13c]alanine (bz-tyr-ala) |
Alanine |
1件: D00012 D00012 💬 |
- |
- |
298 1件: 298 💬 |
292 |
Beta carotene from dunaliella algae |
Beta carotene |
1件: D03101 D03101 💬 |
- |
- |
096 1件: 96 💬 |
293 |
Beta-alanine |
Alanine |
2件: D00012 D00012, D07561 D07561 💬 |
- |
- |
013 1件: 13 💬 |
294 |
Beta-alanine supplementation |
Alanine |
2件: D00012 D00012, D07561 D07561 💬 |
- |
- |
013 1件: 13 💬 |
295 |
Bgj398 (also known as bbp-831) |
- |
- |
- |
- |
276 1件: 276 💬 |
296 |
Biological: umbilical cord based allogenic mesenchymal stem cell |
- |
- |
- |
- |
113 1件: 113 💬 |
297 |
Botox 100 unites allergan (pr1) |
- |
- |
- |
- |
002 1件: 2 💬 |
298 |
Bovine intesastinal alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
046 1件: 46 💬 |
299 |
Bovine intestinal alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
097 1件: 97 💬 |
300 |
Bovine-calf alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
097 1件: 97 💬 |
301 |
Bovine-calf alkaline phosphatase biap |
Alkaline Phosphatase |
- |
- |
- |
097 1件: 97 💬 |
302 |
Brigatinib |
Brigatinib |
1件: D10866 D10866 💬 |
ALK 1件: ALK 💬 |
Non-small cell lung cancer 3件: Non-small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer |
034 1件: 34 💬 |
303 |
Brimonidine |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 2件: 13, 90 💬 |
304 |
Brimonidine tartrate |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 2件: 13, 90 💬 |
305 |
Brimonidine tartrate posterior segment drug delivery system (brimo ps dds) applicator system |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
306 |
Bucelipase alfa |
- |
- |
- |
- |
299 1件: 299 💬 |
307 |
Bupivicaine alone |
- |
- |
- |
- |
298 1件: 298 💬 |
308 |
C. albicans |
- |
- |
- |
- |
046 1件: 46 💬 |
309 |
Caffeine alkaloid |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
310 |
Calcium carbonate and alphacalcidol |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
235 1件: 235 💬 |
311 |
Campath, chemo and/or tbi allo sct |
- |
- |
- |
- |
060 3件: 60, 62, 283 💬 |
312 |
Campath-1h (alemtuzumab) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
060 1件: 60 💬 |
313 |
Caplacizumab (alx-0081) |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
314 |
Caplacizumab (an anti-von willebrand factor nanobody alx-0081) |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
315 |
Carmustine, etoposide, cytarabine, and melphalan (beam) |
Carmustine |
7件: D00125 D00125, D00168 D00168, D00254 D00254, D00369 D00369, D03046 D03046, D03637 D03637, D04107 D04107 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
013 1件: 13 💬 |
316 |
Cd3/cd19 neg allogeneic bmt |
- |
- |
- |
- |
065 1件: 65 💬 |
317 |
Cd3/cd19 negative allogeneic hematopoietic stem cells |
- |
- |
- |
- |
065 1件: 65 💬 |
318 |
Cell-based therapy of autologous adipose derived regenerative cells transplanted intraspinally and intrathecally in als patients |
- |
- |
- |
- |
002 1件: 2 💬 |
319 |
Cellule cd34+ autologhe trasdotte con idua lv codificante per il cdna dell'alfa-l-iduronidasi |
- |
- |
- |
- |
019 1件: 19 💬 |
320 |
Celulas hepatocitos troncales adultas alogenicas de higado expandidas |
- |
- |
- |
- |
251 1件: 251 💬 |
321 |
Celulas madre mesenquimales troncales adultas alogenicas de médula ósea no expandida |
- |
- |
- |
- |
274 1件: 274 💬 |
322 |
Cerezyme (imiglucerase for injection) |
Imiglucerase |
2件: D02810 D02810, D03020 D03020 💬 |
GBA 1件: GBA 💬 |
Lysosome 4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 1件: 19 💬 |
323 |
Cerezyme® / imiglucerase |
Imiglucerase |
2件: D02810 D02810, D03020 D03020 💬 |
GBA 1件: GBA 💬 |
Lysosome 4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 1件: 19 💬 |
324 |
Cerliponase alfa |
Cerliponase alfa |
1件: D10813 D10813 💬 |
TPP1 1件: TPP1 💬 |
Lysosome 1件: Lysosome |
019 1件: 19 💬 |
325 |
Chlorhexidine |
Chlorhexidine |
4件: D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
086 2件: 86, 299 💬 |
326 |
Chlorhexidine gluconate |
Chlorhexidine |
4件: D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 1件: 299 💬 |
327 |
Chlorhexidine gluconate oral rinse |
Chlorhexidine |
4件: D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 1件: 299 💬 |
328 |
Ciclesonide |
Ciclesonide |
1件: D01703 D01703 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
084 1件: 84 💬 |
329 |
Cipaglucosidase alfa |
- |
- |
- |
- |
256 1件: 256 💬 |
330 |
Clobetasol propionate alone |
Clobetasol |
2件: D01272 D01272, D07715 D07715 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
162 1件: 162 💬 |
331 |
Combination of minocycline and mtx or mtx alone |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
046 1件: 46 💬 |
332 |
Combination oral budesonide and rectal hydrocortisone |
Budesonide |
2件: D00088 D00088, D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
333 |
Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator |
Acetate |
2件: D00088 D00088, D00165 D00165 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
334 |
Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) |
Acetate |
21件: D00088 D00088, D00292 D00292, D00472 D00472, D00473 D00473, D00973 D00973, D00975 D00975, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D01998 D01998, D02156 D02156, D02174 D02174, D02591 D02591, D02592 D02592, D03301 D03301, D07749 D07749 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
335 |
Cortef (hydrocortisone) |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
083 1件: 83 💬 |
336 |
Crema de rapamicina al 1% y excipientes |
- |
- |
- |
- |
157 1件: 157 💬 |
337 |
Csm allogéniques issues de cordons ombilicaux ( mti-pp) |
- |
- |
- |
- |
049 1件: 49 💬 |
338 |
Cultured allogeneic fibroblasts |
- |
- |
- |
- |
036 1件: 36 💬 |
339 |
Cyclo[l-alanyl-l-seryl-l-isoleucyl-l-prolyl-l-prolyl-l-glutaminyl-l-lysyl-l-tyrosyl-d-prolyl-l-prolyl-(2s)-2-aminodecanoyl-l-alpha-glutamyl-l-threonyl] |
- |
- |
- |
- |
299 1件: 299 💬 |
340 |
Cytoreductive regimen followed by a cd34+e- selected allogeneic stem cell transplant |
- |
- |
- |
- |
062 1件: 62 💬 |
341 |
Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas |
- |
- |
- |
- |
274 1件: 274 💬 |
342 |
Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas(ref cruzada pei nº 12-088) |
- |
- |
- |
- |
274 1件: 274 💬 |
343 |
D-galactose |
Galactose |
1件: D04291 D04291 💬 |
- |
- |
222 1件: 222 💬 |
344 |
Danicopan (alxn2040) |
Danicopan |
1件: D11641 D11641 💬 |
CFD 1件: CFD 💬 |
Complement and coagulation cascades 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
062 1件: 62 💬 |
345 |
Daratumumab co-formulated with recombinant human hyaluronidase (rhuph20) |
Daratumumab |
4件: D04455 D04455, D04456 D04456, D06604 D06604, D10777 D10777 💬 |
CD38 1件: CD38 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion |
028 1件: 28 💬 |
346 |
Davunetide (al-108, nap) |
Davunetide |
1件: D09401 D09401 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
347 |
Dehydrated alcohol (absolute alcohol) bp for injection |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
279 1件: 279 💬 |
348 |
Device: allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
060 1件: 60 💬 |
349 |
Device: novel allergen-specific immune signature directed approach to dietary elimination therapy |
- |
- |
- |
- |
098 1件: 98 💬 |
350 |
Diagnostic test: memory alteration test (m@t) |
- |
- |
- |
- |
006 1件: 6 💬 |
351 |
Diagnostic test: serum leucine-rich alpha-2 glycoprotein (lrg) levels |
Leucine |
1件: D00030 D00030 💬 |
- |
- |
096 2件: 96, 97 💬 |
352 |
Dimebon alone |
Latrepirdine |
1件: D09917 D09917 💬 |
ACHE 6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 22件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
353 |
Dornase alfa |
Dornase alfa |
1件: D03896 D03896 💬 |
- |
- |
053 2件: 53, 299 💬 |
354 |
Dornase alfa (pulmozyme) |
Dornase alfa |
1件: D03896 D03896 💬 |
- |
- |
299 1件: 299 💬 |
355 |
Dornase alfa [pulmozyme®] |
Dornase alfa |
1件: D03896 D03896 💬 |
- |
- |
299 1件: 299 💬 |
356 |
Dornase alpha |
Dornase alfa |
1件: D03896 D03896 💬 |
- |
- |
299 1件: 299 💬 |
357 |
Dose of 60 mg/kg alpha1-proteinase inhibitor |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 1件: 231 💬 |
358 |
Dose of 60 mg/kg fraction iv-1 alpha1-proteinase inhibitor |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 1件: 231 💬 |
359 |
Dual release hydrocortisone (plenadren) |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
360 |
Efgartigimod alfa |
Efgartigimod alfa |
1件: D11876 D11876 💬 |
- |
- |
014 3件: 14, 35, 63 💬 |
361 |
Egg albumen powder |
Egg |
- |
- |
- |
096 1件: 96 💬 |
362 |
Elosulfase alfa |
Elosulfase alfa |
1件: D10333 D10333 💬 |
GALNS 1件: GALNS 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 1件: 19 💬 |
363 |
Elosulfase alfa 1 mg/ml intravenous solution [vimizim] |
Elosulfase alfa |
1件: D10333 D10333 💬 |
GALNS 1件: GALNS 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 1件: 19 💬 |
364 |
Enbrel - 50 mg soluzione iniettabile in siringa (vetro da 1 ml) preriempita - uso sottocutaneo 12 siringhe preriempite + 24 tamponi imbevuti di alcol |
- |
- |
- |
- |
046 1件: 46 💬 |
365 |
Enterabio's oral parathyroid hormone (1-34) |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
366 |
Enzyme replacement therapy (agalsidase alpha (replagal®)) |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
367 |
Epoetin alfa |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
013 3件: 13, 18, 46 💬 |
368 |
Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan) |
Bosentan |
6件: D01227 D01227, D02008 D02008, D02229 D02229, D07538 D07538, D08514 D08514, D10135 D10135 💬 |
EDNRA 3件: EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
369 |
Erythropoietin |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 9件: 2 , 6 , 13, 18, 22, 47, 70, 95, 96 💬 |
370 |
Erythropoietin human recombinant (eporh) |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
006 1件: 6 💬 |
371 |
Estradiol |
Estradiol |
8件: D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 5件: 13, 46, 49, 226, 299 💬 |
372 |
Estradiol 2 mg |
Estradiol |
8件: D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
299 1件: 299 💬 |
373 |
Estradiol hemihydrate |
Estradiol |
8件: D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 1件: 13 💬 |
374 |
Ethanol |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
051 4件: 51, 97, 279, 280 💬 |
375 |
Ethanol (96 per cent) |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
279 1件: 279 💬 |
376 |
Ethanol 96% gel |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
279 1件: 279 💬 |
377 |
Ethanol 98% solution |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
279 1件: 279 💬 |
378 |
Ethanol bp |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
279 1件: 279 💬 |
379 |
Ethanol gel |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
279 1件: 279 💬 |
380 |
Ethinyl estradiol |
Estradiol |
9件: D00105 D00105, D00554 D00554, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
046 3件: 46, 49, 299 💬 |
381 |
Etn alone |
- |
- |
- |
- |
046 1件: 46 💬 |
382 |
Expanded allogenic adipose-derived adult stem cells |
- |
- |
- |
- |
096 1件: 96 💬 |
383 |
Expanded human allogenic mesemchymal adult stem cells extracted from adipose tissue (eascs) |
- |
- |
- |
- |
096 1件: 96 💬 |
384 |
Expanded human allogenic mesenchymal adult stem cells extractd from adipose tissue (eascs) |
- |
- |
- |
- |
096 1件: 96 💬 |
385 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue |
- |
- |
- |
- |
096 1件: 96 💬 |
386 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eascs |
- |
- |
- |
- |
096 1件: 96 💬 |
387 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eascs) |
- |
- |
- |
- |
096 1件: 96 💬 |
388 |
Fdc macitentan/tadalafil |
Macitentan |
2件: D02008 D02008, D10135 D10135 💬 |
EDNRA 3件: EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
389 |
Filgrastim, alemtuzumab |
Alemtuzumab |
2件: D02802 D02802, D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
065 1件: 65 💬 |
390 |
Firdapse - 10 mg - compresse - uso orale - blister(alu/pvc/pvdc) 100 x 1 compresse |
- |
- |
- |
- |
011 1件: 11 💬 |
391 |
Fludarabine, melphalan, thiotepa |
Fludarabine |
4件: D00369 D00369, D00583 D00583, D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 1件: 65 💬 |
392 |
Fludarabine/ melphalan |
Fludarabine |
3件: D00369 D00369, D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
060 1件: 60 💬 |
393 |
Ga-gcb (velaglucerase alfa) |
Velaglucerase alfa |
1件: D09029 D09029 💬 |
GBA 1件: GBA 💬 |
Lysosome 4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 1件: 19 💬 |
394 |
Galactose |
Galactose |
1件: D04291 D04291 💬 |
- |
- |
171 2件: 171, 222 💬 |
395 |
Gamma-tocopherol |
Tocopherol |
1件: D02332 D02332 💬 |
- |
- |
013 1件: 13 💬 |
396 |
Gene activated human glucocerebrosidase, velaglucerase alfa |
Velaglucerase alfa |
1件: D09029 D09029 💬 |
GBA 1件: GBA 💬 |
Lysosome 4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 1件: 19 💬 |
397 |
Genetic: recombinant adeno-associated virus acid alpha-glucosidase |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
398 |
Givosiran (aln-as1) |
Givosiran |
1件: D11702 D11702 💬 |
ALAS1 1件: ALAS1 💬 |
Biosynthesis of cofactors 4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism |
254 1件: 254 💬 |
399 |
Glucosidase alfa |
- |
- |
- |
- |
256 1件: 256 💬 |
400 |
Guna-antiinterleukin 1 alfa |
- |
- |
- |
- |
046 1件: 46 💬 |
401 |
Heparin & alkalinized lidocaine bladder instillation |
Heparin |
4件: D00358 D00358, D02086 D02086, D07510 D07510, D08127 D08127 💬 |
SCN1A 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 |
Adrenergic signaling in cardiomyocytes 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction |
226 1件: 226 💬 |
402 |
Hla-identical allogeneic mesoangioblasts |
- |
- |
- |
- |
113 1件: 113 💬 |
403 |
Human albumin |
Albumin human |
2件: D02792 D02792, D05424 D05424 💬 |
- |
- |
002 2件: 2 , 96 💬 |
404 |
Human albumin as macroaggregates |
Albumin human |
2件: D02792 D02792, D05424 D05424 💬 |
- |
- |
096 1件: 96 💬 |
405 |
Human albumin solution |
Albumin human |
2件: D02792 D02792, D05424 D05424 💬 |
- |
- |
002 1件: 2 💬 |
406 |
Human allogeneic wj-mscs |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
036 1件: 36 💬 |
407 |
Human anti tnf-alpha monoclonal |
- |
- |
- |
- |
046 1件: 46 💬 |
408 |
Human anti tnf-alpha monoclonal antibody |
- |
- |
- |
- |
046 2件: 46, 84 💬 |
409 |
Human anti-tnf-alpha monoclonal antibody |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
410 |
Human leucocyte interferon-alpha |
- |
- |
- |
- |
013 1件: 13 💬 |
411 |
Human recombinant parathyroid hormone |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
412 |
Human recombinant tissue non-specific alkaline phosphatase fusion protein |
Alkaline Phosphatase |
- |
- |
- |
172 1件: 172 💬 |
413 |
Human serum albumin |
Albumin human |
2件: D02792 D02792, D05424 D05424 💬 |
- |
- |
078 1件: 78 💬 |
414 |
Human serum albumin (hsa) fused to recombinant human growth hormone (hgh) |
Albumin human |
3件: D02691 D02691, D02792 D02792, D05424 D05424 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 1件: 78 💬 |
415 |
Human serum albumin (hsa) fused to somatropin |
Albumin human |
3件: D02691 D02691, D02792 D02792, D05424 D05424 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 1件: 78 💬 |
416 |
Humanized anti-alpha v beta 6 mab |
- |
- |
- |
- |
085 1件: 85 💬 |
417 |
Humanized igg1, kappa anti-serum amyloid a and anti-al amyloid antibody |
- |
- |
- |
- |
028 1件: 28 💬 |
418 |
Hyaluronidase |
Hyaluronidase |
3件: D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
028 4件: 28, 51, 65, 331 💬 |
419 |
Hyaluronidase injected intradermally |
Hyaluronidase |
3件: D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
051 1件: 51 💬 |
420 |
Hydrocortisone |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 9件: 6 , 46, 53, 75, 78, 81, 83, 97, 299 💬 |
421 |
Hydrocortisone (solucortef) |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
422 |
Hydrocortisone 100mg/ml |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
083 1件: 83 💬 |
423 |
Hydrocortisone 10mg |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
046 1件: 46 💬 |
424 |
Hydrocortisone 10mg tablet |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
425 |
Hydrocortisone 10mg tablets |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
426 |
Hydrocortisone 20mg tablets |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
427 |
Hydrocortisone acetate |
Acetate |
2件: D00088 D00088, D00165 D00165 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
428 |
Hydrocortisone cream |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 1件: 6 💬 |
429 |
Hydrocortisone cream 1% |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 1件: 6 💬 |
430 |
Hydrocortisone cream 10mg/g fna fagron |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 1件: 6 💬 |
431 |
Hydrocortisone hydrogen succinate |
Hydrocortisone |
2件: D00088 D00088, D01442 D01442 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
083 1件: 83 💬 |
432 |
Hydrocortisone modified release capsules |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
433 |
Hydrocortisone roussel |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
083 1件: 83 💬 |
434 |
Hydrocortisone sodium acetate |
Acetate |
2件: D00088 D00088, D01779 D01779 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
435 |
Hydrocortisone sodium phosphate |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
053 3件: 53, 81, 83 💬 |
436 |
Hydrocortisone sodium succinate |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 3件: 81, 83, 97 💬 |
437 |
Hydrocortisone tablet 2.5 mg |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
438 |
Hydrocortisone takeda, tabletter |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
078 1件: 78 💬 |
439 |
Hydroxocobalamin |
Hydroxocobalamin |
3件: D01027 D01027, D02707 D02707, D04929 D04929 💬 |
- |
- |
097 1件: 97 💬 |
440 |
Hydroxocobalamin with butyrate |
Butyric Acid |
4件: D01027 D01027, D02707 D02707, D04929 D04929, D05866 D05866 💬 |
- |
- |
097 1件: 97 💬 |
441 |
Hynrcs-allo inj |
- |
- |
- |
- |
002 1件: 2 💬 |
442 |
Ibandronate+alfacalcidol+calcium |
Alfacalcidol |
2件: D01518 D01518, D08056 D08056 💬 |
FDPS 2件: FDPS, VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 8件: Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis |
049 1件: 49 💬 |
443 |
Ibuprofen |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 6件: 13, 46, 65, 113, 271, 299 💬 |
444 |
Ibuprofen 200mg |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 1件: 113 💬 |
445 |
Ibuprofen sandoz 400 mg filmtabletten |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
446 |
Imiglucerase |
Imiglucerase |
2件: D02810 D02810, D03020 D03020 💬 |
GBA 1件: GBA 💬 |
Lysosome 4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 1件: 19 💬 |
447 |
Imiglucerase gz437843 |
Imiglucerase |
2件: D02810 D02810, D03020 D03020 💬 |
GBA 1件: GBA 💬 |
Lysosome 4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 1件: 19 💬 |
448 |
Imiquimod |
Imiquimod |
1件: D02500 D02500 💬 |
TLR7 1件: TLR7 💬 |
Coronavirus disease - COVID-19 5件: Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway |
034 2件: 34, 51 💬 |
449 |
Imiquimod 5% cream |
Imiquimod |
1件: D02500 D02500 💬 |
TLR7 1件: TLR7 💬 |
Coronavirus disease - COVID-19 5件: Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway |
034 2件: 34, 51 💬 |
450 |
Immediate post operative bioassay of parathyroid hormone |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
451 |
Infliximab (ifx alone) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
452 |
Infusion without ald518' |
- |
- |
- |
- |
046 1件: 46 💬 |
453 |
Injection of allogeneic mesenchymal stem cells |
- |
- |
- |
- |
051 1件: 51 💬 |
454 |
Inn parathyroid hormone (1-84) human |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
455 |
Interferon alfa |
Interferon alfa |
1件: D03305 D03305 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
025 5件: 25, 26, 28, 56, 96 💬 |
456 |
Interferon alfa-2a |
Interferon alfa |
2件: D00745 D00745, D03305 D03305 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
056 1件: 56 💬 |
457 |
Interferon alfa-2b |
Interferon alfa |
2件: D02745 D02745, D03305 D03305 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
025 1件: 25 💬 |
458 |
Interferon alpha oral lozenge |
- |
- |
- |
- |
085 1件: 85 💬 |
459 |
Interferon alpha-2a |
Interferon alfa-2a, Recombinant |
1件: D00745 D00745 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
056 1件: 56 💬 |
460 |
Interferon alpha-2b |
Interferon alfa-2b |
1件: D02745 D02745 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
034 1件: 34 💬 |
461 |
Interferon beta-1a (rebif®) alone |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
462 |
Interferon-alpha |
- |
- |
- |
- |
331 1件: 331 💬 |
463 |
Interferon-alpha lozenges |
- |
- |
- |
- |
085 1件: 85 💬 |
464 |
Interferon-alpha2a |
- |
- |
- |
- |
056 1件: 56 💬 |
465 |
Interleukin-2 (aldesleukin). |
Aldesleukin |
1件: D00748 D00748 💬 |
IL2RA 3件: IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction 14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
096 2件: 96, 97 💬 |
466 |
Intrathecal recombinant human alpha iduronidase |
- |
- |
- |
- |
019 1件: 19 💬 |
467 |
Irt laronidase |
Laronidase |
1件: D04670 D04670 💬 |
IDUA 1件: IDUA 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 1件: 19 💬 |
468 |
Jinarc - 15 mg +45 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28x15 mg + 28 x 45 mg) |
- |
- |
- |
- |
067 1件: 67 💬 |
469 |
Jinarc - 15 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 1件: 67 💬 |
470 |
Jinarc - 30 mg + 60 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 60 mg) |
- |
- |
- |
- |
067 1件: 67 💬 |
471 |
Jinarc - 30 mg +90 mg - compressa - uso orale - blister(alu/pvc) in confezione a portafoglio - 56 compresse (28 x 30 mg + 28 x 90 mg) |
- |
- |
- |
- |
067 1件: 67 💬 |
472 |
Jinarc - 30 mg - compressa - uso orale - blister (alu/pvc) - 28 compresse |
- |
- |
- |
- |
067 1件: 67 💬 |
473 |
L-3-(3,4-dihydroxyphenyl)alanine |
Alanine |
1件: D00012 D00012 💬 |
- |
- |
006 1件: 6 💬 |
474 |
L-alanine |
Alanine |
1件: D00012 D00012 💬 |
- |
- |
299 1件: 299 💬 |
475 |
Laronidase |
Laronidase |
1件: D04670 D04670 💬 |
IDUA 1件: IDUA 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 2件: 19, 256 💬 |
476 |
Laronidase ert |
Laronidase |
1件: D04670 D04670 💬 |
IDUA 1件: IDUA 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 1件: 19 💬 |
477 |
Lentivirus alpha-gal a transduced stem cells |
- |
- |
- |
- |
019 1件: 19 💬 |
478 |
Loestrin (norethindrone acetate and ethinyl estradiol) |
Acetate |
11件: D00105 D00105, D00182 D00182, D00554 D00554, D00953 D00953, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 3件: ESR1, ESR2, PGR 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
299 1件: 299 💬 |
479 |
Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol) |
Acetate |
11件: D00105 D00105, D00182 D00182, D00554 D00554, D00953 D00953, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 3件: ESR1, ESR2, PGR 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
046 2件: 46, 49 💬 |
480 |
Long term follow up in all patients who received sar422459 in previous study tdu13583 |
- |
- |
- |
- |
301 1件: 301 💬 |
481 |
Lovastatin |
Lovastatin |
1件: D00359 D00359 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 11件: 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬 |
482 |
Lovastatin 60 mg |
Lovastatin |
1件: D00359 D00359 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
034 1件: 34 💬 |
483 |
Lovastatin ™ |
Lovastatin |
1件: D00359 D00359 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
034 1件: 34 💬 |
484 |
Lovastatin, then minocycline/lovastatin |
Lovastatin |
3件: D00359 D00359, D00850 D00850, D05045 D05045 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
206 1件: 206 💬 |
485 |
Low-dose aldesleukin (proleukin®) |
Aldesleukin |
1件: D00748 D00748 💬 |
IL2RA 3件: IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction 14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 1件: 49 💬 |
486 |
Magnesium gluconate |
Magnesium |
1件: D04835 D04835 💬 |
- |
- |
296 2件: 296, 297 💬 |
487 |
Melphalan |
Melphalan |
1件: D00369 D00369 💬 |
- |
- |
011 15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
488 |
Melphalan fulfenamide hydrochloride |
Melphalan |
1件: D00369 D00369 💬 |
- |
- |
028 1件: 28 💬 |
489 |
Melphalan hydrochloride |
Melphalan |
1件: D00369 D00369 💬 |
- |
- |
060 1件: 60 💬 |
490 |
Melphalan, thalidomide and dexamethasone |
Dexamethasone |
11件: D00292 D00292, D00369 D00369, D00754 D00754, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 2件: NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 1件: 28 💬 |
491 |
Melphalan-flufenamide (melflufen) |
Melphalan |
1件: D00369 D00369 💬 |
- |
- |
028 1件: 28 💬 |
492 |
Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet |
Mesalazine |
2件: D00377 D00377, D02486 D02486 💬 |
- |
- |
097 1件: 97 💬 |
493 |
Mesalazine with hydrocortisone sodium succinate |
Hydrocortisone |
2件: D00088 D00088, D00377 D00377 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
494 |
Methotrexate plus enbrel or enbrel alone |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
495 |
Metoclopramide accord - 10 mg compresse 28 compresse in blister pvc/pvdc/al |
Metoclopramide |
3件: D00726 D00726, D02213 D02213, D05008 D05008 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
051 1件: 51 💬 |
496 |
Minocycline, then minocycline/lovastatin |
Lovastatin |
3件: D00359 D00359, D00850 D00850, D05045 D05045 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
206 1件: 206 💬 |
497 |
Moss-agal (recombinant human alpha-galactosidase a produced in moss) |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
498 |
Myozyme® (alglucosidase alfa) |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
499 |
Nebulized combination ipratropium bromide with salbutamol |
Ipratropium |
2件: D02147 D02147, D02212 D02212 💬 |
ADRB2 6件: ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Adrenergic signaling in cardiomyocytes 17件: Adrenergic signaling in cardiomyocytes, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
500 |
Neogaa or avalglucosidase alfa |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
501 |
Nitazoxanide |
Nitazoxanide |
1件: D02486 D02486 💬 |
- |
- |
096 2件: 96, 97 💬 |
502 |
Nitazoxanide 500mg oral tablet |
Nitazoxanide |
1件: D02486 D02486 💬 |
- |
- |
097 1件: 97 💬 |
503 |
Nle4-d-phe7-alpha-msh |
- |
- |
- |
- |
254 1件: 254 💬 |
504 |
Obyoctocog alfa |
- |
- |
- |
- |
288 1件: 288 💬 |
505 |
Octocog alfa |
Antihemophilic factor, human recombinant |
1件: D02958 D02958 💬 |
- |
- |
288 1件: 288 💬 |
506 |
Oligog-cf5/20, alginate oligosaccharide (g-block) fragment |
Alginic acid |
1件: D02324 D02324 💬 |
- |
- |
299 1件: 299 💬 |
507 |
Oligomer of sodium alginate |
Alginic acid |
1件: D02324 D02324 💬 |
- |
- |
299 1件: 299 💬 |
508 |
Olipudase alfa |
Olipudase alfa |
1件: D10820 D10820 💬 |
SMPD1 1件: SMPD1 💬 |
Lysosome 5件: Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway |
019 1件: 19 💬 |
509 |
Olipudase alfa (rhasm) |
Olipudase alfa |
1件: D10820 D10820 💬 |
SMPD1 1件: SMPD1 💬 |
Lysosome 5件: Lysosome, Metabolic pathways, Necroptosis, Sphingolipid metabolism, Sphingolipid signaling pathway |
019 1件: 19 💬 |
510 |
One alpha |
- |
- |
- |
- |
050 1件: 50 💬 |
511 |
One alpha drops |
- |
- |
- |
- |
050 1件: 50 💬 |
512 |
One-alpha |
- |
- |
- |
- |
050 1件: 50 💬 |
513 |
One-alpha drops |
- |
- |
- |
- |
050 1件: 50 💬 |
514 |
Oral all-trans retinoic acid (atra) |
Tretinoin |
1件: D00094 D00094 💬 |
PML 3件: PML, RARA, RARB 💬 |
Acute myeloid leukemia 12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
094 1件: 94 💬 |
515 |
Ornithine alpha ketoglutarate |
Ornithine |
1件: D08302 D08302 💬 |
- |
- |
245 1件: 245 💬 |
516 |
Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg |
Estradiol |
10件: D00105 D00105, D00554 D00554, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065, D05209 D05209 💬 |
ESR1 3件: ESR1, ESR2, PGR 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
299 1件: 299 💬 |
517 |
Other: continuation of dornase alfa (dnase) |
Dornase alfa |
1件: D03896 D03896 💬 |
- |
- |
299 1件: 299 💬 |
518 |
Other: discontinuation of dornase alfa (dnase) |
Dornase alfa |
1件: D03896 D03896 💬 |
- |
- |
299 1件: 299 💬 |
519 |
Other: functional involvement of identified epigenetic alterations |
- |
- |
- |
- |
102 1件: 102 💬 |
520 |
Other: hydrocortisone |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
075 1件: 75 💬 |
521 |
Other: ibuprofen and isosorbide dinitrate combination |
Ibuprofen |
6件: D00126 D00126, D00347 D00347, D00516 D00516, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 1件: 113 💬 |
522 |
Other: iv steroids combination alone |
- |
- |
- |
- |
041 1件: 41 💬 |
523 |
Other: natural herbs of coconut, aloe vera, and pepperint |
Aloe Vera Leaf |
- |
- |
- |
053 1件: 53 💬 |
524 |
Other: other: symptomatic treatment of als |
- |
- |
- |
- |
002 1件: 2 💬 |
525 |
Other: physalis angulata ethanol extract |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
051 1件: 51 💬 |
526 |
Other: salbutamol nebulisation and with cpap |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
228 1件: 228 💬 |
527 |
Other: withdrawal from alpha1 antitrypsin replacement therapy |
- |
- |
- |
- |
231 1件: 231 💬 |
528 |
Parathyroid hormone |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
070 2件: 70, 235 💬 |
529 |
Parathyroid hormone (1-84) human recombinant |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
530 |
Parathyroid hormone (rdna) |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
531 |
Peg-interferon alpha-2b |
Interferon alfa-2b |
1件: D02745 D02745 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
034 1件: 34 💬 |
532 |
Pegunigalsidase alfa |
Pegunigalsidase alfa |
1件: D11685 D11685 💬 |
- |
- |
019 1件: 19 💬 |
533 |
Pegunigalsidase alpha |
- |
- |
- |
- |
019 1件: 19 💬 |
534 |
Pegylated interferon alfa |
Interferon alfa |
1件: D03305 D03305 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
096 1件: 96 💬 |
535 |
Pegylated interferon alpha2b |
- |
- |
- |
- |
227 1件: 227 💬 |
536 |
Pegylated recombinant human hyaluronidase ph20 |
Hyaluronidase |
3件: D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
028 1件: 28 💬 |
537 |
Pemirolast |
Pemirolast |
2件: D01088 D01088, D07476 D07476 💬 |
- |
- |
113 1件: 113 💬 |
538 |
Pertussis filamentous haemagglutinin adsorbed on aluminium hydroxide |
Aluminium |
1件: D02416 D02416 💬 |
- |
- |
046 1件: 46 💬 |
539 |
Pertussis pertactin adsorbed on aluminium hydroxide |
Aluminium |
1件: D02416 D02416 💬 |
- |
- |
046 1件: 46 💬 |
540 |
Pertussis toxoid adsorbed on aluminium hydroxide |
Aluminium |
1件: D02416 D02416 💬 |
- |
- |
046 1件: 46 💬 |
541 |
Phenytoin |
Phenytoin |
2件: D00512 D00512, D02103 D02103 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 1件: 13 💬 |
542 |
Pioglitazone and tretinoin |
Pioglitazone |
3件: D00094 D00094, D00945 D00945, D08378 D08378 💬 |
PML 4件: PML, PPARG, RARA, RARB 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Longevity regulating pathway, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
002 1件: 2 💬 |
543 |
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate |
Aluminium |
- |
- |
- |
046 1件: 46 💬 |
544 |
Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with n-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-teriparatide (2:1) |
Diethyl ether |
2件: D01772 D01772, D06078 D06078 💬 |
PTH1R 1件: PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
545 |
Positron emission tomography using [11 carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11c]-dasb) and [18 fluorine]-altanserin ([18f]-altanserin) |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
006 1件: 6 💬 |
546 |
Positron emission tomography using [18 fluorine]-altanserin ([18f]-altanserin) |
- |
- |
- |
- |
006 1件: 6 💬 |
547 |
Prednisone 0,5 mg/kg orally on alternate days |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
222 1件: 222 💬 |
548 |
Prednisone alone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 2件: 11, 66 💬 |
549 |
Procedure: alcohol wipes vs. no alcohol wipes |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 1件: 13 💬 |
550 |
Procedure: allo bmt |
- |
- |
- |
- |
065 1件: 65 💬 |
551 |
Procedure: allogeneic bone marrow transplantation |
- |
- |
- |
- |
060 6件: 60, 65, 96, 164, 284, 285 💬 |
552 |
Procedure: allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 8件: 28, 51, 60, 62, 65, 164, 284, 285 💬 |
553 |
Procedure: allogeneic hsc |
- |
- |
- |
- |
065 1件: 65 💬 |
554 |
Procedure: allogeneic hsct |
- |
- |
- |
- |
065 1件: 65 💬 |
555 |
Procedure: allogeneic stem cell transplant |
- |
- |
- |
- |
060 1件: 60 💬 |
556 |
Procedure: allogeneic stem cell transplantation |
- |
- |
- |
- |
019 3件: 19, 20, 62 💬 |
557 |
Procedure: allogenic stem cell transplantation |
- |
- |
- |
- |
060 1件: 60 💬 |
558 |
Procedure: allograft |
- |
- |
- |
- |
070 1件: 70 💬 |
559 |
Procedure: hydrocortisone withdrawal |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
560 |
Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 6件: 28, 51, 60, 62, 65, 285 💬 |
561 |
Procedure: reduced intensity allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
051 1件: 51 💬 |
562 |
Procedure: reduced intensity allogeneic transplant |
- |
- |
- |
- |
049 2件: 49, 51 💬 |
563 |
Procedure: repair of cdh w/alloderm |
- |
- |
- |
- |
294 1件: 294 💬 |
564 |
Procedure: trans-right ventricular alcohol septal ablation (trvasa) |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
058 1件: 58 💬 |
565 |
Propylene glycol-free melphalan hydrochloride |
Melphalan |
2件: D00078 D00078, D00369 D00369 💬 |
- |
- |
028 1件: 28 💬 |
566 |
Prx-102 (pegunigalsidase alfa) |
Pegunigalsidase alfa |
1件: D11685 D11685 💬 |
- |
- |
019 1件: 19 💬 |
567 |
Prx002, elt2, anti-alpha-synuclein monoclonal antibody |
- |
- |
- |
- |
006 1件: 6 💬 |
568 |
Pulmozyme (dornase alfa) |
Dornase alfa |
1件: D03896 D03896 💬 |
- |
- |
299 1件: 299 💬 |
569 |
Pulmozyme (dornase alpha) |
Dornase alfa |
1件: D03896 D03896 💬 |
- |
- |
299 1件: 299 💬 |
570 |
R-salbutamol |
Levosalbutamol |
2件: D02147 D02147, D08124 D08124 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 1件: 49 💬 |
571 |
R-salbutamol sulphate |
Levosalbutamol |
2件: D02147 D02147, D08124 D08124 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 1件: 49 💬 |
572 |
Ramipril |
Ramipril |
1件: D00421 D00421 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
046 7件: 46, 49, 66, 67, 113, 218, 257 💬 |
573 |
Rapamicina tópica al 1% y excipiente |
- |
- |
- |
- |
157 1件: 157 💬 |
574 |
Rcombinant human parathyroid hormone [rhpth(1-84)] |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
575 |
Rebif new formulation + ibuprofen prn |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
576 |
Rebif new formulation + prophylactic ibuprofen |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
577 |
Recombinant adeno-associated viral vector expressing the human alpha-1-antitrypsin gene |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 1件: 231 💬 |
578 |
Recombinant adeno-associated virus 2/6 vector encoding the cdna for human alpha galactosidase a |
- |
- |
- |
- |
019 1件: 19 💬 |
579 |
Recombinant alpha-galactosidase a |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
580 |
Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan avalglucosidase alfa (neogaa) |
Avalglucosidase alfa |
1件: D11744 D11744 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
581 |
Recombinant human acid alfa-glucosidase |
- |
- |
- |
- |
256 1件: 256 💬 |
582 |
Recombinant human acid alfa-glucosidase (atb200) |
- |
- |
- |
- |
256 1件: 256 💬 |
583 |
Recombinant human acid alfa-glucosidase (rhgaa) |
- |
- |
- |
- |
256 1件: 256 💬 |
584 |
Recombinant human acid alpha-glucosidase (rhgaa) |
Alglucosidase alfa |
1件: D03207 D03207 💬 |
GAA 1件: GAA 💬 |
Galactose metabolism 4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 1件: 256 💬 |
585 |
Recombinant human alpha b-crystallin |
- |
- |
- |
- |
013 1件: 13 💬 |
586 |
Recombinant human alpha-galactosidase |
- |
- |
- |
- |
019 1件: 19 💬 |
587 |
Recombinant human alpha-galactosidase abbreviated as r-h-alpha-gal |
- |
- |
- |
- |
019 1件: 19 💬 |
588 |
Recombinant human alpha-mannosidase |
- |
- |
- |
- |
019 1件: 19 💬 |
589 |
Recombinant human alpha-n-acetylglucosaminidase (rhnaglu) |
- |
- |
- |
- |
019 1件: 19 💬 |
590 |
Recombinant human erythropoietin |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
013 1件: 13 💬 |
591 |
Recombinant human erythropoietin(rhepo) |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 1件: 2 💬 |
592 |
Recombinant human hyaluronidase |
Hyaluronidase |
3件: D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
028 2件: 28, 65 💬 |
593 |
Recombinant human hyaluronidase (rhuph20) |
Hyaluronidase |
3件: D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
065 1件: 65 💬 |
594 |
Recombinant human hyaluronidase (rhuph20)+ immune globulin intravenous (igiv) |
Hyaluronidase |
3件: D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
065 1件: 65 💬 |
595 |
Recombinant human hyaluronidase + immune globulin intravenous |
Hyaluronidase |
3件: D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
065 1件: 65 💬 |
596 |
Recombinant human hyaluronidase ph20 |
Hyaluronidase |
3件: D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
028 1件: 28 💬 |
597 |
Recombinant human lysosomal alpha-mannosidase |
- |
- |
- |
- |
019 1件: 19 💬 |
598 |
Recombinant human parathyroid hormone (1-84) |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
599 |
Recombinant human parathyroid hormone [rhpth(1-84)] |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
600 |
Recombinant human serum albumin (hsa) fused to human growth hormone (hgh) |
Albumin human |
3件: D02691 D02691, D02792 D02792, D05424 D05424 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 1件: 78 💬 |
601 |
Recombinant humanized anti-alpha 4 integrin antibody |
- |
- |
- |
- |
013 1件: 13 💬 |
602 |
Recombinant interferon alfa |
Interferon alfa |
1件: D03305 D03305 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
026 2件: 26, 28 💬 |
603 |
Replagal (agalsidase alfa) |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
604 |
Replagal agalsidase alfa |
Agalsidase alfa |
1件: D02784 D02784 💬 |
GLA 1件: GLA 💬 |
Galactose metabolism 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 1件: 19 💬 |
605 |
Reveglucosidase alfa |
- |
- |
- |
- |
256 1件: 256 💬 |
606 |
Reveglucosidase alpha |
- |
- |
- |
- |
256 1件: 256 💬 |
607 |
Rhgaa, acid alpha glucosidase |
- |
- |
- |
- |
256 1件: 256 💬 |
608 |
Rhidu (recombinant human-alpha-l-iduronidase) |
- |
- |
- |
- |
019 1件: 19 💬 |
609 |
Riluzolo teva - 50 mg compresse rivestite con film 90 compresse in blister al/pvc |
- |
- |
- |
- |
114 1件: 114 💬 |
610 |
Rituximab or rituximab hyaluronidase human |
Hyaluronidase |
4件: D02994 D02994, D04455 D04455, D04456 D04456, D06604 D06604 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
331 1件: 331 💬 |
611 |
Rurioctocog alfa pegol |
Rurioctocog alfa pegol |
1件: D10760 D10760 💬 |
- |
- |
288 1件: 288 💬 |
612 |
S.c. injections of bovine intestinal alkaline phosphatase |
Alkaline Phosphatase |
- |
- |
- |
046 1件: 46 💬 |
613 |
Salbutamol |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 9件: 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
614 |
Salbutamol 4mg tablet |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
615 |
Salbutamol sulfate |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
111 1件: 111 💬 |
616 |
Salbutamol sulfate ph. eur. |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
617 |
Salbutamol wzf 4 mg |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
618 |
Sebelipasa alfa |
Sebelipase alfa |
1件: D10377 D10377 💬 |
LIPA 1件: LIPA 💬 |
Cholesterol metabolism 3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 1件: 19 💬 |
619 |
Sebelipase alfa |
Sebelipase alfa |
1件: D10377 D10377 💬 |
LIPA 1件: LIPA 💬 |
Cholesterol metabolism 3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 1件: 19 💬 |
620 |
Sebelipase alfa (sbc-102) |
Sebelipase alfa |
1件: D10377 D10377 💬 |
LIPA 1件: LIPA 💬 |
Cholesterol metabolism 3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 1件: 19 💬 |
621 |
Sebelipase alfa 0.35 mg/kg |
Sebelipase alfa |
1件: D10377 D10377 💬 |
LIPA 1件: LIPA 💬 |
Cholesterol metabolism 3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 1件: 19 💬 |
622 |
Sebelipase alfa 1 mg/kg |
Sebelipase alfa |
1件: D10377 D10377 💬 |
LIPA 1件: LIPA 💬 |
Cholesterol metabolism 3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 1件: 19 💬 |
623 |
Sebelipase alfa 3 mg/kg |
Sebelipase alfa |
1件: D10377 D10377 💬 |
LIPA 1件: LIPA 💬 |
Cholesterol metabolism 3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 1件: 19 💬 |
624 |
Serum albumin |
Albumin human |
2件: D02792 D02792, D05424 D05424 💬 |
- |
- |
078 1件: 78 💬 |
625 |
Serum albumine 5% |
- |
- |
- |
- |
096 1件: 96 💬 |
626 |
Simvastatin alternova |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
627 |
Sitaxsentan alone |
Sitaxentan |
1件: D07171 D07171 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
628 |
Sodium alginate |
Alginic acid |
1件: D02324 D02324 💬 |
- |
- |
299 1件: 299 💬 |
629 |
Solu-cortef (hydrocortisone) |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
083 1件: 83 💬 |
630 |
Spironolactone |
Spironolactone |
1件: D00443 D00443 💬 |
NR3C2 1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
058 7件: 58, 67, 86, 113, 210, 218, 225 💬 |
631 |
Spironolactone (drug) |
Spironolactone |
1件: D00443 D00443 💬 |
NR3C2 1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
210 1件: 210 💬 |
632 |
Spironolactone and conivaptan |
Conivaptan |
3件: D00443 D00443, D01236 D01236, D07748 D07748 💬 |
AVPR1A 3件: AVPR1A, AVPR2, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 6件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
086 1件: 86 💬 |
633 |
Spironolactone captopril carvedilol |
Captopril |
4件: D00251 D00251, D00255 D00255, D00443 D00443, D03415 D03415 💬 |
ACE 7件: ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬 |
AMPK signaling pathway 18件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
634 |
Subcutaneous hydrocortisone |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
635 |
Subcutaneous hydrocortisone 10mg |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 1件: 6 💬 |
636 |
Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin) |
Aldosterone |
3件: D00150 D00150, D02014 D02014, D10528 D10528 💬 |
AGTR1 3件: AGTR1, AGTR2, NR3C2 💬 |
AGE-RAGE signaling pathway in diabetic complications 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 1件: 222 💬 |
637 |
Synthetic human parathyroid hormone 1-34 |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
638 |
Tadalafil |
Tadalafil |
1件: D02008 D02008 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 7件: 6 , 51, 75, 84, 86, 113, 210 💬 |
639 |
Tadalafil 20 mg |
Tadalafil |
1件: D02008 D02008 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
113 1件: 113 💬 |
640 |
Tadalafil 20 mg film-coated tablets |
Tadalafil |
1件: D02008 D02008 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
641 |
Tadalafil 40 mg |
Tadalafil |
1件: D02008 D02008 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
642 |
Tadalafil and ambrisentan upfront combination therapy |
Ambrisentan |
2件: D02008 D02008, D07077 D07077 💬 |
EDNRA 2件: EDNRA, PDE5A 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 2件: 51, 86 💬 |
643 |
Tadalafil and sildenafil |
Sildenafil |
3件: D02008 D02008, D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
113 1件: 113 💬 |
644 |
Tadalafil citrate |
Tadalafil |
1件: D02008 D02008 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
210 1件: 210 💬 |
645 |
Tadalafil oral suspension |
Tadalafil |
1件: D02008 D02008 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
646 |
Tadalafil, placebo |
Tadalafil |
1件: D02008 D02008 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
647 |
Tadalafil- tablet or oral suspension |
Tadalafil |
1件: D02008 D02008 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
648 |
Tadekinig alfa |
Tadekinig alfa |
- |
- |
- |
065 1件: 65 💬 |
649 |
Taliglucerase alfa |
Taliglucerase alfa |
1件: D09675 D09675 💬 |
GBA 1件: GBA 💬 |
Lysosome 4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 1件: 19 💬 |
650 |
Taliglucerase alfa - recombinant human glucocerebrosidase |
Taliglucerase alfa |
1件: D09675 D09675 💬 |
GBA 1件: GBA 💬 |
Lysosome 4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 1件: 19 💬 |
651 |
Tcr alfa beta t cell depletion |
- |
- |
- |
- |
065 1件: 65 💬 |
652 |
Teduglutide (alx-0600) |
Teduglutide |
1件: D06053 D06053 💬 |
GLP2R 1件: GLP2R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
653 |
Tenofovir alafenamide |
Tenofovir |
2件: D06074 D06074, D10428 D10428 💬 |
- |
- |
002 1件: 2 💬 |
654 |
Tenofovir alafenamide (taf) |
Tenofovir |
2件: D06074 D06074, D10428 D10428 💬 |
- |
- |
002 1件: 2 💬 |
655 |
Teriparatide [rdna origin] contains recombinant human parathyroid hormone (1-34) |
Parathyroid hormone |
2件: D05364 D05364, D06078 D06078 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
070 1件: 70 💬 |
656 |
Tetanus + pnemococcal vaccines alone |
- |
- |
- |
- |
046 1件: 46 💬 |
657 |
Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
658 |
Therapeutic allogeneic lymphocytes |
- |
- |
- |
- |
060 3件: 60, 65, 285 💬 |
659 |
Thrombomodulin alfa |
Thrombomodulin Alfa |
1件: D06410 D06410 💬 |
F2 1件: F2 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton |
085 1件: 85 💬 |
660 |
Timolol alcon 0.5% collyre |
Timolol |
3件: D00378 D00378, D00603 D00603, D08600 D08600 💬 |
ADRB1 2件: ADRB1, ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
227 1件: 227 💬 |
661 |
Tnf alpha |
- |
- |
- |
- |
271 1件: 271 💬 |
662 |
Tnf alpha blockers |
- |
- |
- |
- |
046 1件: 46 💬 |
663 |
Tnf alpha inhibitors |
- |
- |
- |
- |
046 1件: 46 💬 |
664 |
Tnf-alpha antagonist and other biotherapy |
- |
- |
- |
- |
046 1件: 46 💬 |
665 |
Tnf-alpha antagonists |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
666 |
Tnf-alpha inhibitor |
- |
- |
- |
- |
046 1件: 46 💬 |
667 |
Tobi podhaler - 28 mg polvere per inalazione capsula rigida uso inalatorio blister(alu/alu) 56 capsule + 1 inalatore |
- |
- |
- |
- |
299 1件: 299 💬 |
668 |
Tocopherol |
Tocopherol |
1件: D02332 D02332 💬 |
- |
- |
013 5件: 13, 49, 206, 257, 298 💬 |
669 |
Tocopherol (vit e) |
Tocopherol |
1件: D02332 D02332 💬 |
- |
- |
257 1件: 257 💬 |
670 |
Tocopherol acetate |
Acetate |
1件: D02332 D02332 💬 |
- |
- |
049 1件: 49 💬 |
671 |
Transplant conditioning with mobilization and alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
065 1件: 65 💬 |
672 |
Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan |
Alemtuzumab |
5件: D00369 D00369, D00583 D00583, D01907 D01907, D02802 D02802, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 2件: 65, 164 💬 |
673 |
Treatment algorithm a |
- |
- |
- |
- |
097 1件: 97 💬 |
674 |
Treatment algorithm b |
- |
- |
- |
- |
097 1件: 97 💬 |
675 |
Treatment algorithm c |
- |
- |
- |
- |
097 1件: 97 💬 |
676 |
Tretinoin |
Tretinoin |
1件: D00094 D00094 💬 |
PML 3件: PML, RARA, RARB 💬 |
Acute myeloid leukemia 12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
002 2件: 2 , 75 💬 |
677 |
Tretinoin and pioglitazone hcl |
Pioglitazone |
3件: D00094 D00094, D00945 D00945, D08378 D08378 💬 |
PML 4件: PML, PPARG, RARA, RARB 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Longevity regulating pathway, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
002 1件: 2 💬 |
678 |
Un-alpha-r |
- |
- |
- |
- |
235 1件: 235 💬 |
679 |
Un-alpha-r 0.25µg |
- |
- |
- |
- |
235 1件: 235 💬 |
680 |
Usan: sebelipasa alfa |
Sebelipase alfa |
1件: D10377 D10377 💬 |
LIPA 1件: LIPA 💬 |
Cholesterol metabolism 3件: Cholesterol metabolism, Lysosome, Steroid biosynthesis |
019 1件: 19 💬 |
681 |
Usan: sebelipase alpha |
- |
- |
- |
- |
019 1件: 19 💬 |
682 |
Velaglucerase alfa |
Velaglucerase alfa |
1件: D09029 D09029 💬 |
GBA 1件: GBA 💬 |
Lysosome 4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 1件: 19 💬 |
683 |
Velaglucerase alfa (vpriv) |
Velaglucerase alfa |
1件: D09029 D09029 💬 |
GBA 1件: GBA 💬 |
Lysosome 4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 1件: 19 💬 |
684 |
Velaglucerasi alfa |
- |
- |
- |
- |
019 1件: 19 💬 |
685 |
Velmanase alfa |
Velmanase alfa |
1件: D11024 D11024 💬 |
MAN2B1 1件: MAN2B1 💬 |
Lysosome 2件: Lysosome, Other glycan degradation |
019 1件: 19 💬 |
686 |
Velmanase alfa (e.g. lamazym) |
Velmanase alfa |
1件: D11024 D11024 💬 |
MAN2B1 1件: MAN2B1 💬 |
Lysosome 2件: Lysosome, Other glycan degradation |
019 1件: 19 💬 |
687 |
Vimizim® (elosulfase alfa) |
Elosulfase alfa |
1件: D10333 D10333 💬 |
GALNS 1件: GALNS 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 1件: 19 💬 |
688 |
Viusid/alzer |
- |
- |
- |
- |
006 1件: 6 💬 |
689 |
Voltarol sr (generics also available in the eu) |
- |
- |
- |
- |
046 1件: 46 💬 |
690 |
Vonicog alfa |
Vonicog Alfa |
1件: D08681 D08681 💬 |
- |
- |
288 1件: 288 💬 |
691 |
Xcel-mc-alpha |
- |
- |
- |
- |
013 1件: 13 💬 |
692 |
Zuglimet - 500 mg compresse rivestite con film 30 compresse in blister pvc/al |
- |
- |
- |
- |
067 1件: 67 💬 |